ClinicalTrials.Veeva

Menu

Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly

T

Technische Universität Dresden

Status

Completed

Conditions

Myelodysplastic Syndromes

Treatments

Other: Observational

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The prospective BoHemE study is designed to evaluate the correlation between bone marrow function and skeletal health in elderly patients (>= 60 years) with or without pre-existing myelodysplastic syndromes (MDS).

Enrollment

297 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria Group 1 (MDS group):

  • Age ≥60 years
  • With known or suspected MDS (according WHO, <20% blast count)
  • Written informed consent

Inclusion Criteria Group 2 (control group):

  • Age ≥60 years
  • Undergoing elective knee or hip replacement therapy
  • Normal blood count (defined by Hb ♀ >12 g/dL, ♂ >13 g/dL; ANC >1.8x10^9/L; PLT >100x10^9/L)
  • Written informed consent

Exclusion Criteria Group 1 (MDS group) + 2 (control group):

  • History of bilateral total hip replacement prior to study
  • Control group only: diagnosis of MDS or AML prior to study
  • Dementia defined as MMSE score of <24
  • Renal insufficiency with an eGFR <30 mL/min
  • Liver cirrhosis Child-Pugh B or C
  • Active infection (HIV, hepatitis B or C, tuberculosis)
  • Heart insufficiency NYHA III or IV or severe cardiac valve disease
  • Prior allogeneic stem cell transplantation

Trial design

297 participants in 2 patient groups

Group 1 (MDS group)
Treatment:
Other: Observational
Group 2 (control group)
Treatment:
Other: Observational

Trial contacts and locations

2

Loading...

Central trial contact

Anna Mies, PhD; Uwe Platzbecker, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems